title: Paraneoplastic pemphigus associated with non-Hodgkin's lymphoma.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Ishigami
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kubo
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Matsudate
authors.forename: Shinichi
authors.initials: S
authors.lastname: Ansai
authors.forename: Seiji
authors.initials: S
authors.lastname: Arase
authors.forename: Bungo
authors.initials: B
authors.lastname: Ohyama
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D015151:Immunoblotting; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000150:complications*; D010392:Pemphigus / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011239:Prednisolone / Q000008:administration & dosage; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone